19/08/2025
New Treatment for Non Cirrhotic MASLD F2-F3
احدث علاج للتليف الكبدى من الدرجه ٢ و ٣ الناتج عن التهاب الكبد الدهنى
https://www.prnewswire.com/news-releases/wegovy-approved-by-fda-for-the-treatment-of-adults-with-noncirrhotic-mash-with-moderate-to-advanced-liver-fibrosis-302531394.html